Multiple genetic alterations, 4q28, a new suppressor region, and potential gender differences in human hepatocellular carcinoma

被引:30
作者
Hammond, C
Jeffers, L
Carr, BI
Simon, D
机构
[1] Med Coll Penn & Hahnemann Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19102 USA
[2] Univ Miami, Miami, FL 33152 USA
[3] Univ Pittsburgh, Pittsburgh, PA USA
关键词
D O I
10.1002/hep.510290513
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary hepatocellular carcinomas (HCCs) of different etiologies were studied to determine the rate of alteration of several genetic regions previously associated with the HCC phenotype. The focus of our study was to identify the frequency of genetic alterations within individual HCCs and their distribution among male and female cases. Genetic differences were evaluated between DNA isolated from tumor (T) and corresponding non-tumor (N) tissue using short tandem repeat (STR)-microsatellites and restriction fragment length polymorphism (RFLP) analyses. Twenty-eight HCC cases were studied with polymorphic markers from different parts of the genome. Three or more loci were identified with genetic alterations from 28 loci tested in 63% of HCC cases. The highest frequency of alteration occurred in the chromosome regions lp36, 13q14, 17p13, and the 4q28 region identified in HCCs for the first time. High loss of heterozygosity (LOH) in lp36, 4q28, 13q14, and 17p13 regions indicates important HCC suppressors within the regions. The study documents no association between cause and specific genetic change or their frequency in HCCs analyzed. The data document a significant gender distortion for genetic alteration in chromosome 13q14 and 17p13 regions and a concordant gender alteration rate in the lp36 and 4q28 regions. An overall higher frequency of genetic alterations was identified in male cases. Future study with an extended number of HCC cases should substantiate the frequency of alteration between genders and identify tentative suppressors in the lp36 and 4q28 regions.
引用
收藏
页码:1479 / 1485
页数:7
相关论文
共 50 条
[1]  
BEASLEY RP, 1981, LANCET, V2, P1129
[2]  
Becker SA, 1996, CANCER RES, V56, P5092
[3]   PRESENCE OF INTEGRATED HEPATITIS-B VIRUS-DNA SEQUENCES IN CELLULAR DNA OF HUMAN HEPATOCELLULAR-CARCINOMA [J].
BRECHOT, C ;
POURCEL, C ;
LOUISE, A ;
RAIN, B ;
TIOLLAIS, P .
NATURE, 1980, 286 (5772) :533-535
[4]   SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA [J].
BRESSAC, B ;
KEW, M ;
WANDS, J ;
OZTURK, M .
NATURE, 1991, 350 (6317) :429-431
[5]   HEPATITIS-B VIRUSES AND HEPATOCELLULAR-CARCINOMA [J].
BUENDIA, MA .
ADVANCES IN CANCER RESEARCH, 1992, 59 :167-226
[6]   LOSS OF HETEROZYGOSITY SUGGESTS TUMOR SUPPRESSOR GENE RESPONSIBLE FOR PRIMARY HEPATOCELLULAR-CARCINOMA [J].
BUETOW, KH ;
MURRAY, JC ;
ISRAEL, JL ;
LONDON, WT ;
SMITH, M ;
KEW, M ;
BLANQUET, V ;
BRECHOT, C ;
REDEKER, A ;
GOVINDARAJAH, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8852-8856
[7]   Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan [J].
Chou, YHW ;
Chung, KC ;
Jeng, LB ;
Chen, TC ;
Liaw, YF .
CANCER LETTERS, 1998, 123 (01) :1-6
[8]   Human/mouse homology relationships [J].
DeBry, RW ;
Seldin, MF .
GENOMICS, 1996, 33 (03) :337-351
[9]   LOSS OF CONSTITUTIONAL HETEROZYGOSITY ON CHROMOSOME-5Q IN HEPATOCELLULAR-CARCINOMA WITHOUT CIRRHOSIS [J].
DING, SF ;
HABIB, NA ;
DOOLEY, J ;
WOOD, C ;
BOWLES, L ;
DELHANTY, JDA .
BRITISH JOURNAL OF CANCER, 1991, 64 (06) :1083-1087
[10]  
EMI M, 1992, CANCER RES, V52, P5368